Sign Up
OverviewAPI
The Immuno Oncology Assays Market is poised to expand significantly, with a projected growth from USD 3.91 billion in 2020 to USD 11.29 billion by 2029 at a CAGR of 12.5%. Key players such as Luminex Corporation and Thermo Fisher Scientific Inc. are driving advancements in the field. Notably, Diasorin's submission of the LIAISON® LymeDetect® test to the FDA marks a notable development.

Ask a question